Literature DB >> 30007530

Factors associated with how often community pharmacists offer and dispense naloxone.

Delesha M Carpenter1, Aditi K Dhamanaskar2, Kelsea L Gallegos3, Greene Shepherd4, Sherita L Mosley5, Courtney A Roberts5.   

Abstract

BACKGROUND: A recent Surgeon General's report encourages people to ask pharmacists about naloxone, but whether pharmacists are well-prepared to respond to these requests is unclear.
OBJECTIVES: Determine factors that are associated with how often pharmacists offer and dispense naloxone.
METHODS: A convenience sample of 457 community pharmacists in North Carolina completed a 5-min online survey. Linear regressions were conducted to identify factors that are associated with how often pharmacists offer and dispense naloxone. Pharmacists' self-reported barriers to teaching naloxone administration were identified.
RESULTS: Most pharmacists (81.2%) worked in pharmacies that stocked naloxone, but many never offered (36.6%) or dispensed (19.4%) naloxone. Pharmacists offered (β = 0.15, p < 0.01) and dispensed (β = 0.15, p < 0.01) naloxone more often when their pharmacy stocked more naloxone formulations. Pharmacists who were more comfortable discussing naloxone offered it more often (β = 0.26, p = 0.001). Pharmacists who worked in regional/local/grocery chain pharmacies dispensed and offered naloxone less often than other pharmacy types. Barriers to teaching naloxone administration included: time constraints, inadequate training, and perceived lack of patient comprehension.
CONCLUSIONS: Many community pharmacists do not offer or dispense naloxone. Pharmacists who are uncomfortable discussing naloxone or work at smaller chain pharmacies may benefit from targeted naloxone training.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Education; Health communication; Naloxone; Pharmacists

Year:  2018        PMID: 30007530     DOI: 10.1016/j.sapharm.2018.07.008

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  6 in total

1.  Evaluating Pharmacy Student Consultations with Standardized Patients on Opioid Medication Use and Opioid-Specific Risks.

Authors:  Tanvee Thakur; Meredith Frey; Betty Chewning
Journal:  Am J Pharm Educ       Date:  2019-12       Impact factor: 2.047

2.  A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.

Authors:  Hawraa Sameer Sajwani; Anna V Williams
Journal:  Harm Reduct J       Date:  2022-10-20

3.  Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access.

Authors:  Sara S McMillan; Hidy Chan; Laetitia H Hattingh
Journal:  Pharmacy (Basel)       Date:  2021-04-26

4.  Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial.

Authors:  Ashley Cid; Alec Patten; Michael Beazely; Kelly Grindrod; Jennifer Yessis; Feng Chang
Journal:  Pharmacy (Basel)       Date:  2022-02-04

5.  Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.

Authors:  Rachel A Parry; William A Zule; Christopher B Hurt; Donna M Evon; Sarah K Rhea; Delesha M Carpenter
Journal:  Harm Reduct J       Date:  2021-07-08

6.  Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts.

Authors:  Claire Duvallet; Bryan D Hayes; Timothy B Erickson; Peter R Chai; Mariana Matus
Journal:  Prev Chronic Dis       Date:  2020-08-20       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.